atezolizumab 1200 MG in 20 ML Injection
- RxCUI
- 1792780
- RxNorm name
- atezolizumab 1200 MG in 20 ML Injection
- Display name
- atezolizumab 1200 MG in 20 ML Injection
- Full name
- atezolizumab 1200 MG in 20 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761034 | Tecentriq | atezolizumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TECENTRIQ | ATEZOLIZUMAB | Genentech, Inc. | 6fa682c9-a312-4932-9831-f286908660ee | 2026-05-20 | Warnings, Adverse reactions | 1792780 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6fa682c9-a312-4932-9831-f286908660ee | atezolizumab 1200 MG in 20 ML Injection [PSN] · 20 ML atezolizumab 60 MG/ML Injection [SCD] · atezolizumab 1200 MG per 20 ML Injection [SY] | 3 | 45 | These highlights do not include all the information needed to use TECENTRIQ safely and effectively. See full prescribing information for TECENTRIQ. TECENTRIQ ® (atezolizumab) injection, for intravenous use Initial U.S. Approval: 2016 | 20260520 |